Sexual Dimorphism in Brown Adipose Tissue Activation and White Adipose Tissue Browning.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
26 Jul 2022
Historique:
received: 30 06 2022
revised: 25 07 2022
accepted: 25 07 2022
entrez: 28 7 2022
pubmed: 29 7 2022
medline: 30 7 2022
Statut: epublish

Résumé

The present narrative review gathers the studies reported so far, addressing sex differences in the effects of cold exposure, feeding pattern and age on brown adipose tissue (BAT) thermogenesis and white adipose tissue (WAT) browning. In rodents, when exposed to decreasing temperatures, females activate thermogenesis earlier. Results obtained in humans go in the same line, although they do not provide results as solid as those obtained in rodents. Regarding the effects of overfeeding, interesting sex differences on BAT thermogenic capacity have been reported, and the greater or lower sensitivity of each sex to this dietary situation seems to be dependent on the type of feeding. In the case of energy restriction, females are more sensitive than males. In addition, sex differences have also been observed in thermogenesis changes induced by phenolic compound administration. During sexual development, an increase in BAT mass and BAT activity takes place. This phenomenon is greater in boys than in girls, probably due to its relation to muscle-mass growth. The opposite situation takes place during ageing, a lifespan period where thermogenic capacity declines, this being more acute in men than in women. Finally, the vast majority of the studies have reported a higher susceptibility to developing WAT browning amongst females. The scarcity of results highlights the need for further studies devoted to analysing this issue, in order to provide valuable information for a more personalised approach.

Identifiants

pubmed: 35897816
pii: ijms23158250
doi: 10.3390/ijms23158250
pmc: PMC9368277
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Salud Carlos III
ID : CB12/03/30007
Organisme : Instituto de Salud Carlos III
ID : CB12/03/30007

Références

Front Physiol. 2019 Feb 08;10:83
pubmed: 30800077
Mol Cell Endocrinol. 2021 Aug 1;533:111336
pubmed: 34090969
Nutrients. 2018 Dec 20;11(1):
pubmed: 30577445
Endocrinology. 2003 Nov;144(11):4923-30
pubmed: 12959998
Mol Cell Endocrinol. 2021 Aug 1;533:111337
pubmed: 34062167
Exp Physiol. 2019 Feb;104(2):168-173
pubmed: 30468689
Cell Physiol Biochem. 2008;22(1-4):337-46
pubmed: 18769061
Int J Obes (Lond). 2019 Feb;43(2):384-391
pubmed: 30185921
FEBS J. 2021 Jun;288(12):3628-3646
pubmed: 32621398
Mol Cell Endocrinol. 2021 Aug 20;534:111365
pubmed: 34126190
Cell Physiol Biochem. 2011;28(5):933-48
pubmed: 22178945
J Pediatr. 2012 Apr;160(4):604-609.e1
pubmed: 22048045
J Am Coll Cardiol. 2016 Jan 19;67(2):136-138
pubmed: 26791058
PLoS One. 2013 May 08;8(5):e63391
pubmed: 23667608
Physiol Rep. 2019 Mar;7(6):e14031
pubmed: 30873754
Mol Nutr Food Res. 2018 Nov;62(21):e1800463
pubmed: 30095217
Biol Sex Differ. 2016 Dec 9;7:67
pubmed: 27990249
Int J Obes (Lond). 2020 Jan;44(1):226-234
pubmed: 30705393
J Physiol Biochem. 2019 Feb;75(1):1-10
pubmed: 30506389
Cell Metab. 2014 Jul 1;20(1):41-53
pubmed: 24856932
J Endocrinol. 2019 May 10;241(3):R97-R109
pubmed: 31144796
Biochim Biophys Acta Mol Basis Dis. 2017 Nov;1863(11):2715-2726
pubmed: 28711599
J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1148-e1158
pubmed: 34677618
Biochem J. 1991 Oct 15;279 ( Pt 2):575-9
pubmed: 1953651
Endocrinology. 2013 Sep;154(9):2992-3000
pubmed: 23782940
Cell. 2012 Jul 20;150(2):366-76
pubmed: 22796012
Pflugers Arch. 1998 Oct;436(5):689-95
pubmed: 9716701
Obesity (Silver Spring). 2020 Feb;28(2):241-246
pubmed: 31970907
Gend Med. 2007 Dec;4(4):359-66
pubmed: 18215727
Front Endocrinol (Lausanne). 2020 Apr 21;11:222
pubmed: 32373072
Cell Physiol Biochem. 2007;19(1-4):195-204
pubmed: 17310113
Am J Physiol. 1987 Feb;252(2 Pt 2):R402-8
pubmed: 3812777
J Clin Endocrinol Metab. 2013 Jul;98(7):E1218-23
pubmed: 23780370
Mol Cell Endocrinol. 2021 Jul 1;531:111310
pubmed: 33989715
Genes Nutr. 2014 Jan;9(1):372
pubmed: 24292948
Physiol Behav. 2008 May 23;94(2):178-86
pubmed: 18281067
Pflugers Arch. 1999 Oct;438(5):628-34
pubmed: 10555559
PLoS One. 2014 Jan 31;9(1):e87405
pubmed: 24498099
Biol Sex Differ. 2015 Apr 03;6:7
pubmed: 25866617
Mol Metab. 2017 Oct;6(10):1198-1211
pubmed: 29031720
Biol Chem. 2020 Oct 16;402(2):123-132
pubmed: 33544474
J Gerontol A Biol Sci Med Sci. 2020 May 22;75(6):1042-1049
pubmed: 30561530
Curr Opin Lipidol. 2018 Jun;29(3):180-185
pubmed: 29718003
Obesity (Silver Spring). 2015 Aug;23(8):1671-9
pubmed: 26179979
J Pediatr. 2019 Jul;210:166-172.e1
pubmed: 30979545
Cell Metab. 2019 Apr 2;29(4):932-949.e4
pubmed: 30639359
Front Cardiovasc Med. 2020 Feb 25;7:22
pubmed: 32158768
Am J Physiol Endocrinol Metab. 2005 Jul;289(1):E15-22
pubmed: 15701677
Front Endocrinol (Lausanne). 2021 Apr 13;12:652444
pubmed: 33927694
Cell Metab. 2012 Sep 5;16(3):348-62
pubmed: 22940198
Rev Endocr Metab Disord. 2022 Feb;23(1):31-41
pubmed: 33712997
PLoS One. 2013 Oct 23;8(10):e77221
pubmed: 24194874
Med Sci Sports Exerc. 1988 Oct;20(5 Suppl):S185-92
pubmed: 3057320
Mol Nutr Food Res. 2014 Nov;58(11):2122-32
pubmed: 25047917
Nat Rev Endocrinol. 2021 May;17(5):276-295
pubmed: 33627836
J Clin Endocrinol Metab. 2020 May 1;105(5):
pubmed: 32144431
Adipocyte. 2014 Jan 1;3(1):4-9
pubmed: 24575363
Oncotarget. 2016 Jul 26;7(30):46959-46971
pubmed: 27409675
Trends Endocrinol Metab. 2018 Sep;29(9):651-666
pubmed: 30017740
Obes Res. 2004 Sep;12(9):1455-63
pubmed: 15483210
Nat Rev Endocrinol. 2017 Jan;13(1):26-35
pubmed: 27616452
Diabetes. 2010 Jul;59(7):1789-93
pubmed: 20357363
Nature. 2008 Aug 21;454(7207):961-7
pubmed: 18719582
Sci Rep. 2016 Dec 06;6:38579
pubmed: 27922125
Int J Obes (Lond). 2021 Aug;45(8):1773-1781
pubmed: 34002038
Pflugers Arch. 2001 Jun;442(3):396-403
pubmed: 11484771
Pharm Res. 2021 Apr;38(4):549-567
pubmed: 33783666

Auteurs

Iker Gómez-García (I)

Nutrition and Obesity Group, Department of Pharmacy and Food Sciences, Faculty of Pharmacy, University of the Basque Country (UPV/EHU) and Lucio Lascaray Research Institute, 01006 Vitoria-Gasteiz, Spain.

Jenifer Trepiana (J)

Nutrition and Obesity Group, Department of Pharmacy and Food Sciences, Faculty of Pharmacy, University of the Basque Country (UPV/EHU) and Lucio Lascaray Research Institute, 01006 Vitoria-Gasteiz, Spain.
BIOARABA Health Research Institute, 01006 Vitoria-Gasteiz, Spain.
CIBERobn Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, 01006 Vitoria-Gasteiz, Spain.

Alfredo Fernández-Quintela (A)

Nutrition and Obesity Group, Department of Pharmacy and Food Sciences, Faculty of Pharmacy, University of the Basque Country (UPV/EHU) and Lucio Lascaray Research Institute, 01006 Vitoria-Gasteiz, Spain.
BIOARABA Health Research Institute, 01006 Vitoria-Gasteiz, Spain.
CIBERobn Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, 01006 Vitoria-Gasteiz, Spain.

Marta Giralt (M)

CIBERobn Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, 01006 Vitoria-Gasteiz, Spain.
Department of Biochemistry and Molecular Biomedicine, Faculty of Biology and Institute of Biomedicine at the University of Barcelona (IBUB), Universitat de Barcelona, 08028 Barcelona, Spain.

María P Portillo (MP)

Nutrition and Obesity Group, Department of Pharmacy and Food Sciences, Faculty of Pharmacy, University of the Basque Country (UPV/EHU) and Lucio Lascaray Research Institute, 01006 Vitoria-Gasteiz, Spain.
BIOARABA Health Research Institute, 01006 Vitoria-Gasteiz, Spain.
CIBERobn Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, 01006 Vitoria-Gasteiz, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH